SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland · Delayed Price · Currency is CHF 1.070
0.00 (0.00%)
Aug 24, 2026, 10:57 AM CET
SHL Telemedicine Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 40 | 44 | 43 | 114 | 216 | 276 | |
Market Cap Growth | 53.59% | 2.61% | -62.59% | -47.37% | -21.68% | 121.10% |
Enterprise Value | 30 | 45 | 43 | 112 | 223 | 248 |
Last Close Price | 1.07 | 1.18 | 1.43 | 3.82 | 8.14 | 10.51 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 7.31 | 7.31 | 7.31 | 7.31 | 7.31 |
PS Ratio | 0.85 | 0.94 | 0.83 | 2.37 | 3.97 | 6.11 |
PB Ratio | 1.14 | 1.26 | 1.20 | 1.77 | 3.95 | 4.99 |
P/TBV Ratio | 3.86 | 4.26 | 4.12 | 4.48 | 23.91 | 78.41 |
P/OCF Ratio | - | - | - | - | - | 1638.60 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.64 | 0.96 | 0.84 | 2.34 | 4.08 | 5.49 |
EV/EBITDA Ratio | - | - | - | - | - | 62.62 |
EV/EBIT Ratio | - | - | - | - | - | 1290.94 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.30 | 0.30 | 0.41 | 0.26 | 0.45 | 0.54 |
Debt / EBITDA Ratio | - | - | - | - | 192.39 | 7.47 |
Net Debt / Equity Ratio | -0.28 | -0.28 | -0.04 | -0.08 | 0.14 | 0.01 |
Net Debt / EBITDA Ratio | 4.40 | 4.40 | 0.23 | 1.18 | -3.31 | 0.10 |
Net Debt / FCF Ratio | 3.67 | 3.67 | 1.06 | 2.30 | -4.64 | -1.00 |
Asset Turnover | 0.71 | 0.71 | 0.59 | 0.51 | 0.49 | 0.51 |
Inventory Turnover | 24.89 | 24.89 | 13.39 | 8.67 | 7.87 | 8.97 |
Quick Ratio | 1.18 | 1.18 | 0.95 | 2.05 | 1.56 | 2.37 |
Current Ratio | 1.25 | 1.25 | 1.03 | 2.30 | 1.81 | 2.64 |
Return on Equity (ROE) | -37.04% | -37.04% | -47.97% | -10.10% | 0.36% | -28.23% |
Return on Assets (ROA) | -4.37% | -4.37% | -5.59% | -4.34% | -2.69% | 0.14% |
Return on Invested Capital (ROIC) | -18.29% | -16.64% | -16.06% | -11.31% | -1.32% | 0.41% |
Return on Capital Employed (ROCE) | -10.40% | -10.40% | -16.00% | -8.10% | -5.60% | 0.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -30.75% | -27.88% | -59.74% | -5.22% | -0.03% | -4.66% |
FCF Yield | -6.64% | -6.02% | -2.81% | -2.06% | -0.74% | -0.14% |
Buyback Yield / Dilution | -30.75% | -30.75% | -0.59% | -7.22% | -7.71% | -34.33% |
Total Shareholder Return | -30.75% | -30.75% | -0.59% | -7.22% | -7.71% | -34.33% |